Table 1.

Baseline Characteristics Between Cohorts with and without Use of Red Yeast Rice Prescription

	No RYR N=34367		RYR prescription N=34367		p-value
	n	(%)	n	(%)
Sex					1.0000
Female	19741	(57.4)	19,741	(57.4)
Male	14626	(42.6)	14,626	(42.6)
Age, years					1.0000
20–29	407	(1.2)	407	(1.2)
30–39	1920	(5.6)	1920	(5.6)
40–49	6582	(19.2)	6582	(19.2)
50–59	13,417	(39.0)	13,417	(39.0)
60–69	8548	(24.9)	8548	(24.9)
70–79	3016	(8.8)	3016	(8.8)
≥80	477	(1.4)	477	(1.4)
Low income					1.0000
No	33854	(98.5)	33,854	(98.5)
Yes	513	(1.5)	513	(1.5)
Number of hospitalizations					1.0000
0	18,338	(53.4)	18,338	(53.4)
1	7062	(20.6)	7062	(20.6)
2	3130	(9.1)	3130	(9.1)
≥3	5837	(17.0)	5837	(17.0)
Number of emergency visits					1.0000
0	12,111	(35.2)	12,111	(35.2)
1	7216	(21.0)	7216	(21.0)
2	4259	(12.4)	4259	(12.4)
≥3	10,781	(31.4)	10,781	(31.4)
Medical conditions
Hypertension	17814	(51.8)	17,814	(51.8)	1.0000
Diabetes	11844	(34.5)	11,844	(34.5)	1.0000
Mental disorders	13805	(40.2)	13,805	(40.2)	1.0000
COPD	2025	(5.9)	2025	(5.9)	1.0000
Ischemic heart disease	5904	(17.2)	5904	(17.2)	1.0000
Heart failure	618	(1.8)	618	(1.8)	1.0000
Renal dialysis	217	(0.6)	217	(0.6)	1.0000
CCI, score					1.0000
0	7055	(20.5)	7055	(20.5)
1	7260	(21.1)	7260	(21.1)
2	4942	(14.4)	4942	(14.4)
≥3	15,110	(44.0)	15,110	(44.0)
Anti-hypertension drug use					1.0000
No	22290	(64.9)	22,290	(64.9)
Yes	12077	(35.1)	12,077	(35.1)
Anticoagulant drug use					1.0000
No	33925	(98.7)	33,925	(98.7)
Yes	442	(1.3)	442	(1.3)
NASH					0.0007
No	29507	(85.9)	29,195	(85.0)
Yes	4860	(14.1)	5172	(15.0)
Obesity					<0.0001
No	33502	(97.5)	33,254	(96.8)
Yes	865	(2.5)	1113	(3.2)

Abbreviations: CCI, Charlson comorbidity index; NASH, non-alcoholic steatohepatitis; RYR, red yeast rice.